CSI Market
Sign In | Register

Guided Therapeutics Inc (GTHP) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access GTHP Annual Cash Flow →
The quarterly cash flow data below helps track how Guided Therapeutics Inc's liquidity profile has evolved over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-2.72
Depreciation & amortization0.00
Amortization of Other Assets0.09
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.05
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.08
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Gain On Debt Renigotiated-
Bad Debt Recovery-
Bad Debt Expense-
Non Employee Stock Based Compensation-
Nonemployee Share Based Compensation-
Stock Issued During Period Value Issued For Debt Repayment-
Stock Issued During Period Value Issued For Accrued Interest Of Debt Repaid-
Dividends Preferred Stock-
Increase Decrease In Subscription Receivable-
Change In Fair Value Of Warrants-
Other Non Current Assetss-
Increase Decrease In Fair Value Of Warrants-
Change In Fair Value Of Derivatives-
Finance Lease Right Of Use Asset Amortization-
Expense For Warrants Issued To Consultants-
Derivative Gain Loss On Derivative Net-0.01
Increase Decrease In Operating Lease Liability-0.01
Gain From Forgiveness Of Debt0.00
Income taxes0.00
Unrealized Gain (Loss) on Derivatives0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities0.10
Increase (Decrease) in Accrued Liabilities0.00
Increase (Decrease) in Customer Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital-0.08
Other Noncash Expense0.01
Other net0.00
Payments for (Proceeds from) Other Operating Activities1.54
Discontinued operations0.00
Net Cash flow from Operating Activities-0.94
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.30
Other borrowing transactions-0.05
Long-term debt - borrowings0.30
Long-term debt - repayments-0.35
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.98
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.30
Proceeds From Issuance Of Convertible Notes Related Party-
Proceed From Issuance Of Common Stock-
Proceeds From Issuance Of Common Stock Other-
Proceeds For Future Issuance Of Common Stock-
Proceeds From Issuance Of Series D Convertible Preferred Stock-
Proceeds From Issuance Of Series E Convertible Preferred Stock-
Proceeds From Issuance Of Series E Preferred Stock-
Proceeds From Series F2 Offering Net Of Costs-
Note Payable Default Penalty-
Redemption Of Series G Preferred Stock-
Payments Made On Notes Payable-
Proceeds From Issuances Of Warrants Net Of Costs-
Proceeds From Issuance Of Common Stock Net Of Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.89
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.94
Total Cash Flow-0.05
4 historic quarters locked

Sign in to unlock the full Guided Therapeutics Inc cash flow history.

Sign In Create Free Account

About Guided Therapeutics Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 13, 2026
  • Source: gthp_10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001477932-26-004958

Figures are derived from filed reports and may be restated. Historical data is subject to revision.